At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19.
HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge, our team is applying its expertise to deploy a novel vaccination approach against COVID-19.
B2C
1 to 25
Funded
$6,354,000
Scaling Up
2013
Healthcare
Health Care Facilities & Hospitals
Biotechnology
N/A
Cure Genetic Diseases, Fighting Cancer and COVID-19 With Synthetic Biology
N/A
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
N/A
Software
Potential Customers
Interested in what they do or partnership?
Learn more about how they work